5-bromo-N-(2-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)amino)ethyl)-6-oxo-1,6-dihydropyridine-3-carboxamide

Catalog No. :
ACFTZU567
CAS No. :
-
Molecular Formula :
C21H18BrN5O6
Molecular Weight :
516.31

IUPAC Name:5-bromo-N-(2-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)amino)ethyl)-6-oxo-1,6-dihydropyridine-3-carboxamide

5-bromo-N-(2-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)amino)ethyl)-6-oxo-1,6-dihydropyridine-3-carboxamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$599.00Login to see priceIn stockInquiry
250mg95%$1194.00Login to see priceIn stockInquiry
1g95%$3574.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-bromo-N-(2-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)amino)ethyl)-6-oxo-1,6-dihydropyridine-3-carboxamide
IUPAC Name5-bromo-N-(2-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)amino)ethyl)-6-oxo-1,6-dihydropyridine-3-carboxamide
Molecular FormulaC21H18BrN5O6
Molecular Weight516.31
SMILESO=C1CCC(N2C(=O)C3=CC=CC(NCCNC(=O)C4=CNC(=O)C(Br)=C4)=C3C2=O)C(=O)N1
InChI KeyXSHNXHVRWQYXMO-UHFFFAOYSA-N

Synthetic Route by SureRoute

1. ACFTZU567 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACMJFR352 route compound structure diagram
    ACMJFR3521957235-67-4 In Stock
  2. Plus
  3. ACDQFK479 route compound structure diagram
    ACDQFK47941668-13-7 In Stock
  4. Then
  5. ACFTZU567 route product structure diagram
    ACFTZU567- In Stock
Inquiry

2. ACFTZU567 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACEKYA823 route compound structure diagram
    ACEKYA823169773-94-8 In Stock
  2. Plus
  3. ACMJFR352 route compound structure diagram
    ACMJFR3521957235-67-4 In Stock
  4. Then
  5. ACFTZU567 route product structure diagram
    ACFTZU567- In Stock
Inquiry

Comments (0)